Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

27.60
-0.9450-3.31%
Volume:6.51M
Turnover:178.91M
Market Cap:3.48B
PE:-5.91
High:28.49
Open:28.48
Low:27.05
Close:28.54
52wk High:43.15
52wk Low:25.77
Shares:126.00M
Float Shares:123.00M
Volume Ratio:1.12
T/O Rate:5.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.52
PE(LYR):-8.64

Loading ...

Mar 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2023

Major Issues Report

8-K - Current report
Jan 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2022

Major Issues Report

8-K - Current report
Oct 26, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2022

Major Issues Report

8-K - Current report
Jul 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 26, 2022

Major Issues Report

8-K - Current report
Apr 27, 2022

Major Issues Report

8-K - Current report
Apr 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 03, 2021

Major Issues Report

8-K - Current report
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]